Mostrar el registro sencillo del ítem
Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis
dc.contributor | Universitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna | |
dc.contributor.author | Garin, Noe | |
dc.contributor.author | Zarate-Tamames, Borja | |
dc.contributor.author | Gras-Martin, Laura | |
dc.contributor.author | Milà, Raimon | |
dc.contributor.author | Crespo-Lessmann, Astrid | |
dc.contributor.author | Curto, Elena | |
dc.contributor.author | Hernández Hernández, Marta | |
dc.contributor.author | Mestres Miralles, Concepción | |
dc.contributor.author | Plaza Moral, Vicente | |
dc.date.accessioned | 2024-01-14T16:50:08Z | |
dc.date.available | 2024-01-14T16:50:08Z | |
dc.date.created | 2023-02 | |
dc.date.issued | 2023-03 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14342/3718 | |
dc.description.abstract | We conducted a systematic review and meta-analysis to gain insight into the characteristics and clinical impact of electronic monitoring devices of inhalers (EMDs) and their clinical interventions in adult patients with asthma or COPD. The search included PubMed, Web of Science, Cochrane, Scopus and Embase databases, as well as official EMDs websites. We found eight observational studies and ten clinical trials, assessing a wide range of clinical outcomes. Results from the meta-analysis on adherence to inhalers in a period over three months were favourable in the EMD group (fixed effects model: SMD: 0.36 [0.25–0.48]; random effects model SMD: 0.41 [0.22–0.60]). An exploratory meta-analysis found an improvement in ACT score (fixed effect model SMD: 0.25 [0.11–0.39]; random effects model: SMD: 0.47 [−0.14–1.08]). Other clinical outcomes showed mixed results in the descriptive analyses. The findings of this review highlight the benefits of EMDs in the optimization of adherence to inhaled therapy as well as the potential interest in other clinical outcomes. | ca |
dc.format.extent | 25 p. | ca |
dc.language.iso | eng | ca |
dc.publisher | MDPI | ca |
dc.relation.ispartof | Pharmaceuticals, 2023, vol. 16, núm. 3, 414 | ca |
dc.rights | © L'autor/a | ca |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.other | Asma | ca |
dc.subject.other | Pulmons -- Malalties obstructives | ca |
dc.subject.other | COPD | ca |
dc.subject.other | Inhaladors | ca |
dc.subject.other | Medicaments -- Monitoratge | ca |
dc.subject.other | Metaanàlisi | ca |
dc.title | Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis | ca |
dc.type | info:eu-repo/semantics/article | ca |
dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
dc.embargo.terms | cap | ca |
dc.subject.udc | 615 | ca |
dc.subject.udc | 616.2 | ca |
dc.identifier.doi | https://doi.org/10.3390/ph16030414 | ca |
dc.description.version | info:eu-repo/semantics/publishedVersion | ca |